Phosphoinositide (4,5) Bisphosphate as a Diagnostic Tool and Target for Cancer Treatment
申请人:Janetopoulos Christopher
公开号:US20160266129A1
公开(公告)日:2016-09-15
The present invention relates to PI(4,5)P2 and more particularly to use of enzymes that metabolize and regulate the PI(4,5)P2 levels as a as a target for cancer treatment. Furthermore, measuring the level of PI(4,5)P2 or the degree of turnover of PI(4,5)P2 in cancer cells is an important diagnostic tool.